• For readers wondering whether UnitedHealth Group is starting to look like value after a rough stretch, this article explains what the current share price may be implying about the company.
• The stock most recently closed at US$269.54, following declines of 5.6% over 7 days, 7.1% over 30 days and 19.9% year to date, with a 46.3% decline over the past year.
• Recent headlines have focused on UnitedHealth Group as investors reassess large US healthcare names, with market commentary often pointing to shifting expectations for the sector and regulatory scrutiny. This backdrop helps explain why some investors are questioning whether recent share price moves have reset expectations too far or not far enough.
• According to Simply Wall St's valuation checks, UnitedHealth Group has a value score of 5 out of 6. The rest of this article will walk through what that score means across different methods, then conclude with a way to view these valuation tools in a clearer big-picture context.

Approach 1: UnitedHealth Group Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model projects a company’s future cash flows and then discounts those projections back to today, aiming to estimate what the business might be worth right now based purely on cash it could generate for shareholders.

For UnitedHealth Group, the latest twelve month Free Cash Flow is about US$15.8b. Analysts and Simply Wall St projections extend this through a 2 Stage Free Cash Flow to Equity model, with estimates and extrapolations running out to 2035. Within this, projected Free Cash Flow for 2030 is US$27.8b, with years between 2026 and 2035 supported by a mix of analyst inputs and Simply Wall St extrapolated figures.

Bringing those projected cash flows back to today, the model produces an estimated intrinsic value of US$816.71 per share. Relative to the recent share price of US$269.54, this suggests the stock is around 67.0% undervalued based on these cash flow assumptions.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests UnitedHealth Group is undervalued by 67.0%. Track this in your watchlist or portfolio, or discover 55 more high quality undervalued stocks.

Approach 2: UnitedHealth Group Price vs Earnings

For a profitable company, the P/E ratio is a useful shorthand for what the market is currently willing to pay for each dollar of earnings, which makes it a common way for investors to compare valuations across similar businesses.

What counts as a “normal” P/E often reflects how the market views a company’s growth outlook and risk profile, with higher expected growth or lower perceived risk typically linked to higher P/E levels, and the reverse also being true.

UnitedHealth Group currently trades on a P/E of 20.29x, compared with the Healthcare industry average of 21.22x and a peer group average of 18.82x. Simply Wall St also calculates a proprietary “Fair Ratio” of 37.06x for UnitedHealth Group, which represents the P/E that might be expected after considering factors such as earnings growth characteristics, industry, profit margins, market cap and company specific risks.

This Fair Ratio is designed to be more tailored than a simple comparison with peers or the broad industry. It adjusts for those company specific features rather than assuming all Healthcare names deserve similar multiples. With the current P/E of 20.29x sitting well below the Fair Ratio of 37.06x, the P/E based view suggests the shares may be undervalued on these inputs.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your UnitedHealth Group Narrative

Earlier the DCF and P/E work suggested that valuation can look quite different depending on the inputs. Narratives take that further by letting you attach a clear story to your numbers. On Simply Wall St’s Community page you can pick or build a UnitedHealth Group view that links your assumptions about future revenue, earnings and margins to a forecast and a Fair Value. You can then compare that Fair Value with today’s price and see how it updates when new news or earnings arrive. You might lean closer to a higher Fair Value case such as about US$625 per share, or to a lower case nearer US$284. This shows how two investors can look at the same company data and reasonably reach very different conclusions.

Do you think there's more to the story for UnitedHealth Group? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.